BYS-02

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameBYS-02
Drug Alias Nameceftriamidine sodiumcephalosporin triazine amidine sodiumtoubaoqinmi sodiumsmall molecule therapeutic (Guangzhou Baiyunshan Pharmaceutical)BYS-02 +[6] 
ClassificationSmall molecules
Mechanisms of ActionBacterial cell wall synthesis inhibitors
TargetsUpdating
Therapy Area/IndicationsPneumoniaBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesGuangzhou Baiyunshan Pharmaceutical Holdings Company Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGuangzhou Baiyunshan Pharmaceutical Holdings Company LtdSouth China Center For Innovative Pharmaceuticals
Inactive CompaniesN/A
Active IndicationsPneumoniaBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A